Discovery

Development

Testing

Clinical Manufacture

Commercial Manufacture

Drug Product Fill & Finish

Antibody Drug Conjugates

Technologies & Platforms

WuXi Biologics provides a comprehensive, integrated and highly customizable range of services for the discovery, development and manufacturing of biologics. We are the only open-access biologics technology platform in the world offering end-to-end solutions to empower anyone to discover, develop and manufacture biologics from concept to commercial manufacturing. We provide the world with the ONE true single-source approach that saves our clients critical time and money.

Our truly ONE integrated and open-access service platform greatly expedites drug development.


Utilizing our one-stop service offering, single project management team and a supply chain only 1-2 hours apart, WuXi Biologics eliminates the time-consuming project hand-offs and troubleshooting issues that come with the conventional multi-vendor drug development model. (Learn More)

The WuXi Biologics Difference

Experience &
Expertise

leadership-01-01
We provide industry-leading experts and solutions from concept to commercialization.

Learn more

Quality &
Performance

Picture2

Our track record demonstrates our commitment to meeting global regulatory standards.

Learn more

Capacity &
Capabilities

capability word cloud-02

We provide the expertise and facilities to get your program efficiently from idea to market.

Learn more

Gateway
to China

gateway

Let our team help you access one of the largest healthcare markets in the world.

Learn more

Experience & Expertise

Experience

WuXi’s leadership team consists of industry experts with 15-20 years of experience in biological drug development in the U.S./EU. While at WuXi this team has contributed to 1 BLA and 40 worldwide INDs in just 2 years!

Expertise

WuXi has over 150+ returnees from large pharma and small biotechs in the U.S./EU. These scientists cover all facets of drug development from discovery to manufacture of final drug product.

Training

WuXi Biologics makes training a high priority and all of our scientists and engineers go through rigorous training regimens before working on your critical programs.

Solution Provider

Due to our extensive experience and expertise we are uniquely suited to help solve your development dilemmas. Whether your issues are time or technical, our team of industry experts is there to provide solutions.

Quality & Performance

We provide a quality system and operations that meet worldwide regulatory standards. We have routinely and successfully passed audits by our clients, EU Qualified Persons (QPs) and former U.S. FDA inspectors.

numbers-on-home-page-01

Partners worldwide including 11 of the 20 largest pharma

numbers-on-home-page-02

Successful client GMP audits

40-03

Global IND-enabling CMC projects since 2014

1-04

BLA for which we manufactured the drug substance and drug product

Capacity and Capabilities

We have strong technical capabilities and an open-access technology platform that allows our customers to initiate a project at any stage in the development process. We have assembled one of the largest biologics development teams in the global biologics industry with 678 scientists (as of September 30, 2016). We also operate one of the world’s largest cell culture development laboratories with over 260 bioreactors with individual capacity ranging from 1L to 200L. We are currently building the world’s largest disposable bioreactor-based biologics commercial manufacturing facilities with a planned manufacturing capacity of 30,000L.

Discovery

Discovery

WuXi provides 5 technology platforms and a fully integrated discovery engine that includes research materials generation and antibody developability and manufacturability assessment.

Learn More

Development

Development

With one of the world’s largest biologics development teams we cover all aspects of your product development including cell line engineering, assay, formulation and upstream and downstream process development.

Learn More

Testing

Testing

WuXi Biologics maintains Asia’s first non-state run biosafety lab for viral clearance, CLC and UPB testing. Protein characterization, release and stability testing is also available in-house.

Learn More

Clinical
Manufacture

Clinical Manufacture

WuXi utilizes disposable bioreactors for fed-batch and perfusion manufacturing (50 L to 2,000 L) in two separate facilities (Wuxi and Shanghai).

Learn More

Commercial
Manufacture

Commercial Manufacture

We are constructing the world’s largest disposable bioreactor-based biologics commercial manufacturing facilities with a planned manufacturing capacity of 30,000L.

Learn More

Formulation,
Fill & Finish

1

Liquid Drug Product / Parenteral formulation, fill & finish (up to 12,000 vials/hr or 100,000 vials/batch) is available as is lyophilization.

Learn More

Gateway to China

China has the world’s largest population, 2nd largest economy and 3rd largest healthcare market. Thus, most companies are evaluating how to address China’s unmet medical needs. WuXi Biologics can provide unprecedented regulatory and technical support for any organization looking to enter clinical trials or to market its biotherapeutic in China. Contact us about partnering opportunities in China.

The Joint Venture between Medimmune and WuXi was just the first example of how we are assisting drug development organizations worldwide to bring critical medicine to patients in China.

BACK